Handelsavisen
prelaunch
Companies Healthcare 2291.HK
22
2291.HK HKEX Medical Equipment, Supplies & Distribution

Lepu Scientech Medical Technology Shanghai Co Ltd

HK$11,55
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
4,0B HKD
P/E
16,4x
EV / Rev
Div yield
4,91 %
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Lepu Scientech Medical Technology Shanghai Co Ltd is a medical equipment and supplies company that operates within the healthcare services and equipment sector.

Business. Lepu Scientech Medical Technology Shanghai Co Ltd (2291.HK) is a healthcare services and equipment company operating in the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, including capital equipment and consumables. Headquartered in Shanghai, the company is primarily listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not provided.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target28,47

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
28,47
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
16,4x
P/E
Analysts
Buy
1 analysts · indicative
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 2291.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 2291.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Lepu Scientech Medical Technology Shanghai Co Ltd (2291.HK) is a healthcare services and equipment company operating in the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, including capital equipment and consumables. Headquartered in Shanghai, the company is primarily listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not provided.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Lepu Scientech has a market capitalization of 3.93 billion CNY, with a current market price of 11.34 CNY per share. The company has 346.75 million shares outstanding, with no dilution from preferred or convertible shares, as the diluted and basic shares are equal. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

    Profitability metrics are not available in the current dataset, and no direct comparison to industry medians can be made. Analysts have assigned a mean price target of 28.47 CNY, significantly higher than the current market price, indicating a potential upside of 150.75%. The mean recommendation score of 2.00 suggests a generally positive outlook, with one "buy" rating and no "strong buy" or "hold" ratings.

    The company's geographic and segment exposure is not disclosed in the available data, making it difficult to assess revenue concentration or regional performance. Analysts have not provided segment-specific guidance, and the company has not disclosed revenue by geographic region or business line.

    Growth trajectory is not quantified in the current dataset, but the analyst price targets suggest a strong growth expectation. The company has not provided forward-looking revenue guidance for the current or next fiscal year, and no numeric deltas are available to assess growth direction.

    Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. Dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuance. No adjustments have been applied to the valuation metrics, and no dilution sources are identified in the available documents.

    Recent events include the publication of analyst price targets and recommendations, but no filings or transcripts are available in the current dataset to provide further insight into the company's operations or strategic direction.

    Key takeaways
    • Analysts assign a high mean price target of 28.47 CNY, suggesting a potential 150.75% upside from the current market price.
    • The company has no dilution from preferred or convertible shares, with basic and diluted shares equal at 346.75 million.
    • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
    • No segment or geographic revenue breakdown is available, limiting visibility into revenue concentration.
    • Analysts have issued one "buy" rating and no "strong buy" or "hold" ratings, indicating a generally positive outlook.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2026-04-23
    FY 2026 · Full-year highlights

    Revenue ¥527.9M, +11,9% YoY; Operating income −3,4% YoY.

    Revenue¥527.9M+11,9 % YoY
    Operating income¥276.5M−3,4 % YoY
    Net income¥239.7M−2,4 % YoY
    Free cash flow-¥16.1M−17,5 % YoY
    EPS
    Operating cash flow¥221.1M−0,6 % YoY
    Financials
    Income statement
    Revenue¥527.9M
    Gross profit¥447.0M
    Operating income¥276.5M
    Net income¥239.7M
    Margins
    Gross margin84.7%
    Operating margin52.4%
    Net margin45.4%
    FCF margin-3.1%
    Balance sheet
    Total assets¥2.10B
    Total liabilities¥62.0M
    Total equity¥2.04B
    Cash & equivalents
    Long-term debt¥773.0k
    Cash flow
    Operating cash flow¥221.1M
    CapEx-¥76.4M
    Free cash flow-¥16.1M
    SBC
    P&L flow · revenue → net income
    Revenue ¥527.9MOperating costs ¥251.4MTax ¥36.8MNet income ¥239.7M
    Highlights
    • Revenue ¥527.9M, +11,9% YoY
    • Operating income −3,4% YoY
    • Net income −2,4% YoY
    • Free cash flow −17,5% YoY
    • Net margin 45.4%

    Valuation FY

    Market price
    HK$11,55
    Market cap
    HK$3.93B
    Enterprise value
    P/E
    16.4x
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price targetHK$28,47 · Median HK$28,47
    Low HK$28,00High HK$28,94

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowHK$28,00
    MeanHK$28,47
    MedianHK$28,47
    HighHK$28,94
    SpotHK$11,55
    +146.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Lepu Scientech Medical Technology Shanghai Co Ltd Market data — financials · 2026-05-26
    • Lepu Scientech Medical Technology Shanghai Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    2291.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-04-23 05:55 UTCEARNINGSAnnual results — FY 2026 Revenue CNY 527.9M · Net CNY 239.7M
    2025-03-28 20:23 UTCEARNINGSAnnual results — FY 2025 Revenue CNY 471.6M · Net CNY 245.6M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage